Search

News

  • news
    03.11.2017 "Smart" nanoparticles are the key to defeating cancer

    Scientists from the University of Surrey have presented nanoparticles that can be heated to a high temperature and can destroy cancer cells. In addition, these nanoparticles independently regulate their temperature and cool down, in order to prevent the damage of healthy tissues.

  • news
    02.11.2017 Researchers learned more about diabetes

    The team of scientists has found why the blood enzyme dipeptidylpeptidase-4 (DPP4) concentration is increased in diabetics. Perhaps the discovery of the scientists will lead to the development of new methods of treating diabetes, Zee News reports.

  • news
    01.11.2017 Discovery: the skin plays an important role in regulating blood pressure

    A study was carried out on genetically modified mice. The scientists have revealed that the skin can affect the pressure and heart rate when the level of oxygen in the environment changes. As we know, due to lack of oxygen, the blood flow to the heart increases. This process is partially regulated by specific proteins - hypoxia induced factors (HIFs), Business Standard reports.

  • news
    31.10.2017 The new method will allow to assess the degree of maturity of the brain in premature infants

    As we know, premature birth is dangerous for the brain. Now the level of development of the brain in infants born prematurely can be assessed by means of electroencephalography (EEG) and artificial intelligence. According to Zee News, the method was developed by scientists from the University of Helsinki.

  • news
    26.10.2017 A unique compound makes cancer cells to kill themselves

    The researchers have revealed a compound capable to destroy cancer cells without harm to healthy cells. It helps with acute myeloid leukemia (AML). However, it is likely that the compound is able to fight other types of cancer, Zee News reports.

  • news
    24.10.2017 Scientists have tested new vaccines against Ebola

    The experiment was carried out in 1500 persons over 18 years old from Monrovia (Liberia) without a history of Ebola disease. Three groups (500 people per group) received one vaccine or a placebo (saline solution), The Deccan Chronicle reports.

  • news
    23.10.2017 Scientists have made a breakthrough in a study of human genome

    Members of Researchers International Consortium Genotype-Tissue Expression have presented the results of decoding of a genome project obtained after studying 22,000 different gene structures, RSUTE reports. The findings should be used by experts to create new medicines, including anti-cancer drugs.

  • news
    20.10.2017 Genetics have revealed the basis of bacterial resistance to antibiotics

    Scientists have revealed 76 new genes that make bacteria resistant to the most powerful antibiotics. These genes were identified in the study of large amounts of bacterial DNA, Zee News reports. As it turned out, some of the described genes protect bacteria from carbapenems - the last defense line antibiotics working against even multidrug-resistant pathogens.

  • news
    18.10.2017 As it turned out cholesterol and cancer have been linked in an unexpected way

    The University of Illinois has clearly shown how a cholesterol metabolism byproduct (27HC molecule) affects specific immune cells in such a way that they begin to support the spread of cancer. So, a group of researchers have revealed an abnormal activity among immune cells (neutrophils and T cells) at the sites of metastases with a high 27HC level

  • news
    17.10.2017 New tablets against diabetes are ready to make a real revolution in medicine

    As Health Day notes the injectable diabetic medicine - glucagon-like peptide-1 (GLP-1) - may be released in the form of tablets. Experimental tablets have already been tested on volunteers. More than 1100 people with type 2 diabetes participated in the trials lasting 26 weeks. People were divided into several groups. In the one group, 1 mg Semaglutide injections were performed weekly. Five other groups were given different dosages orally - 2.5, 5, 10, 20 or 40 mg. Another group was given an oral dosage form of the drug with a constant increase in dosage. There was also a placebo group.